Iconic Therapeutics Inc.

Iconic Therapeutics is targeting tissue factor, a protein that decorates pathological vessels but is not found on normal tissue. The start-up has created a bi-functional protein capable of homing in on TF-laden cells and triggering their destruction. Studies in animal models of AMD show that injection of the therapy results in the regression of up to 50% of unwanted blood vessels.